In a 12-month period that has seen drug compounders linked to horse deaths at a training center and integrity issues at the track, the Kentucky Horse Racing Commission is researching ways it could add regulatory oversight.
The U.S. Food and Drug Administration reports the number of Thoroughbreds who died after receiving a compounded drug from Wickliffe Pharmacy in Lexington, Ky. has grown to four, and six others have become ill.
The RMTC will recommend the anabolic steroid stanozolol, currently permitted for therapeutic use up to 30 days prior to racing, be eliminated from the list of substances with a recommended threshold level.
Scientists are warning horse owners and veterinarians to be cautious about using compounded (private pharmacy-mixed) gastric ulcer medications.
Most Popular Stories
- Benzel to Handle de Sousa's Book in NY
- Promising Youth on Display in Futurity
- Dortmund Back to Training After Injury
- Half Sisters to Preakness Winners Race Sunday
- KY Downs Ready for Meet With Record Purses
- American Pharoah to Continue Racing
- Ben's Cat Still After Third Turf Monster Win
- Pedigree Analysis: Caro
- CHRB Committee Advances New Lasix Proposal
- Dialed In Colt Leads Louisiana Yearling Sale